BioHarvest Sciences Inc. (NASDAQ:BHST - Get Free Report)'s share price shot up 2.1% during mid-day trading on Tuesday . The stock traded as high as $6.89 and last traded at $6.87. 2,920 shares were traded during trading, a decline of 70% from the average session volume of 9,695 shares. The stock had previously closed at $6.73.
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on the company. HC Wainwright reaffirmed a "buy" rating and set a $14.00 price target on shares of BioHarvest Sciences in a research report on Tuesday, April 8th. Craig Hallum began coverage on BioHarvest Sciences in a report on Monday, May 5th. They set a "buy" rating and a $15.00 target price on the stock.
Check Out Our Latest Research Report on BioHarvest Sciences
BioHarvest Sciences Trading Up 1.2%
The company has a market capitalization of $113.30 million, a PE ratio of -13.80 and a beta of 0.65. The business has a fifty day moving average of $6.66 and a 200 day moving average of $6.09.
BioHarvest Sciences (NASDAQ:BHST - Get Free Report) last released its earnings results on Thursday, May 15th. The company reported ($0.13) earnings per share for the quarter, topping analysts' consensus estimates of ($0.15) by $0.02. BioHarvest Sciences had a negative net margin of 31.30% and a negative return on equity of 307.04%. The firm had revenue of $7.64 million for the quarter, compared to analyst estimates of $8.93 million. Equities analysts forecast that BioHarvest Sciences Inc. will post -0.8 EPS for the current fiscal year.
Institutional Investors Weigh In On BioHarvest Sciences
Several large investors have recently modified their holdings of the stock. TD Waterhouse Canada Inc. acquired a new stake in shares of BioHarvest Sciences in the 4th quarter worth approximately $69,000. True North Advisors LLC increased its position in BioHarvest Sciences by 7.6% during the first quarter. True North Advisors LLC now owns 44,391 shares of the company's stock worth $275,000 after purchasing an additional 3,120 shares during the last quarter. Finally, Magnus Financial Group LLC boosted its holdings in BioHarvest Sciences by 105.0% in the first quarter. Magnus Financial Group LLC now owns 71,733 shares of the company's stock valued at $444,000 after acquiring an additional 36,733 shares during the last quarter.
BioHarvest Sciences Company Profile
(
Get Free Report)
BioHarvest Sciences Inc is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications.
Further Reading
Before you consider BioHarvest Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioHarvest Sciences wasn't on the list.
While BioHarvest Sciences currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
